vs
Side-by-side financial comparison of NATIONAL BANKSHARES INC (NKSH) and Verastem, Inc. (VSTM). Click either name above to swap in a different company.
NATIONAL BANKSHARES INC is the larger business by last-quarter revenue ($15.3M vs $11.2M, roughly 1.4× Verastem, Inc.). NATIONAL BANKSHARES INC runs the higher net margin — 38.5% vs -876.3%, a 914.8% gap on every dollar of revenue.
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
NKSH vs VSTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.3M | $11.2M |
| Net Profit | $5.9M | $-98.5M |
| Gross Margin | — | — |
| Operating Margin | 47.4% | -362.2% |
| Net Margin | 38.5% | -876.3% |
| Revenue YoY | 24.7% | — |
| Net Profit YoY | 91.0% | -311.1% |
| EPS (diluted) | $0.93 | $-1.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.3M | — | ||
| Q3 25 | $14.2M | $11.2M | ||
| Q2 25 | $13.3M | $2.1M | ||
| Q1 25 | $12.8M | — | ||
| Q4 24 | $12.2M | — | ||
| Q3 24 | $11.7M | $0 | ||
| Q2 24 | $10.9M | $10.0M | ||
| Q1 24 | $10.4M | — |
| Q4 25 | $5.9M | — | ||
| Q3 25 | $4.4M | $-98.5M | ||
| Q2 25 | $2.3M | $-25.9M | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $2.7M | $-24.0M | ||
| Q2 24 | $-307.0K | $-8.3M | ||
| Q1 24 | $2.2M | — |
| Q4 25 | 47.4% | — | ||
| Q3 25 | 37.9% | -362.2% | ||
| Q2 25 | 20.0% | -2047.9% | ||
| Q1 25 | 30.5% | — | ||
| Q4 24 | 30.1% | — | ||
| Q3 24 | 27.5% | — | ||
| Q2 24 | -4.4% | -182.8% | ||
| Q1 24 | 25.8% | — |
| Q4 25 | 38.5% | — | ||
| Q3 25 | 31.1% | -876.3% | ||
| Q2 25 | 17.2% | -1213.6% | ||
| Q1 25 | 25.3% | — | ||
| Q4 24 | 25.1% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | -2.8% | -82.6% | ||
| Q1 24 | 20.8% | — |
| Q4 25 | $0.93 | — | ||
| Q3 25 | $0.69 | $-1.35 | ||
| Q2 25 | $0.36 | $-0.62 | ||
| Q1 25 | $0.51 | — | ||
| Q4 24 | $0.50 | — | ||
| Q3 24 | $0.42 | $-0.60 | ||
| Q2 24 | $-0.05 | $-0.31 | ||
| Q1 24 | $0.37 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.3M | $137.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $184.9M | $-15.5M |
| Total Assets | $1.8B | $176.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $59.3M | — | ||
| Q3 25 | $42.3M | $137.7M | ||
| Q2 25 | $92.8M | $164.3M | ||
| Q1 25 | $122.5M | — | ||
| Q4 24 | $108.1M | — | ||
| Q3 24 | $49.8M | $113.2M | ||
| Q2 24 | $98.9M | $83.4M | ||
| Q1 24 | $121.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $40.5M | ||
| Q2 24 | — | $40.3M | ||
| Q1 24 | — | — |
| Q4 25 | $184.9M | — | ||
| Q3 25 | $179.2M | $-15.5M | ||
| Q2 25 | $168.7M | $36.1M | ||
| Q1 25 | $167.3M | — | ||
| Q4 24 | $156.4M | — | ||
| Q3 24 | $167.8M | $11.1M | ||
| Q2 24 | $149.0M | $18.9M | ||
| Q1 24 | $139.4M | — |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.8B | $176.9M | ||
| Q2 25 | $1.8B | $196.3M | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.8B | $126.4M | ||
| Q2 24 | $1.8B | $105.7M | ||
| Q1 24 | $1.7B | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.66× | ||
| Q2 24 | — | 2.14× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.9M | $-36.2M |
| Free Cash FlowOCF − Capex | $15.2M | — |
| FCF MarginFCF / Revenue | 99.2% | — |
| Capex IntensityCapex / Revenue | 17.9% | — |
| Cash ConversionOCF / Net Profit | 3.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | $23.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.9M | — | ||
| Q3 25 | $6.1M | $-36.2M | ||
| Q2 25 | $2.1M | $-32.7M | ||
| Q1 25 | $2.6M | — | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $3.1M | $-23.8M | ||
| Q2 24 | $-3.0M | $-27.6M | ||
| Q1 24 | $3.8M | — |
| Q4 25 | $15.2M | — | ||
| Q3 25 | $5.3M | — | ||
| Q2 25 | $1.5M | — | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $6.2M | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $-4.0M | $-27.6M | ||
| Q1 24 | $3.5M | — |
| Q4 25 | 99.2% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | 12.5% | — | ||
| Q4 24 | 50.5% | — | ||
| Q3 24 | 18.5% | — | ||
| Q2 24 | -36.3% | -275.8% | ||
| Q1 24 | 33.8% | — |
| Q4 25 | 17.9% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 7.5% | — | ||
| Q4 24 | 26.6% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 9.3% | 0.1% | ||
| Q1 24 | 3.0% | — |
| Q4 25 | 3.04× | — | ||
| Q3 25 | 1.38× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 3.07× | — | ||
| Q3 24 | 1.17× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
